» Articles » PMID: 37892645

Exploring the Genetic Causes for Postnatal Growth Failure in Children Born Non-Small for Gestational Age

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Oct 28
PMID 37892645
Authors
Affiliations
Soon will be listed here.
Abstract

The most common causes of short stature (SS) in children are familial short stature (FSS) and idiopathic short stature (ISS). Recently, growth plate dysfunction has been recognized as the genetic cause of FSS or ISS. The aim of this study was to investigate monogenic growth failure in patients with ISS and FSS. Targeted exome sequencing was performed in patients categorized as ISS or FSS and the subsequent response to growth hormone (GH) therapy was analyzed. We found 17 genetic causes involving 12 genes (, , , , , , , , , , , and ) and 2 copy number variants. A genetic cause was found in 45.5% and 35.7% of patients with FSS and ISS, respectively. The genetic yield in patients with syndromic and non-syndromic SS was 90% and 23.1%, respectively. In the 11 genetically confirmed patients, a gain in height from -2.6 to -1.3 standard deviations after 2 years of GH treatment was found. The overall diagnostic yield in this study was 41.7%. We identified several genetic causes involving paracrine signaling, the extracellular matrix, and basic intracellular processes. Identification of the causative gene may provide prognostic evidence for the use of GH therapy in non-SGA children.

Citing Articles

Monogenic causes of familial short stature.

Plachy L, Dusatkova P, Amaratunga S, Neuman V, Sumnik Z, Lebl J Front Endocrinol (Lausanne). 2025; 15:1506323.

PMID: 39749023 PMC: 11693446. DOI: 10.3389/fendo.2024.1506323.

References
1.
Luo C, Yang Y, Yin B, Chen J, Huang C, Zhang W . Microduplication of 3p25.2 encompassing RAF1 associated with congenital heart disease suggestive of Noonan syndrome. Am J Med Genet A. 2012; 158A(8):1918-23. DOI: 10.1002/ajmg.a.35471. View

2.
Aubert-Mucca M, Janel C, Porquet-Bordes V, Patat O, Touraine R, Edouard T . Clinical heterogeneity of NADSYN1-associated VCRL syndrome. Clin Genet. 2023; 104(1):114-120. DOI: 10.1111/cge.14328. View

3.
Mintz C, Seaver L, Irons M, Grimberg A, Lozano R . Focused Revision: ACMG practice resource: Genetic evaluation of short stature. Genet Med. 2021; 23(5):813-815. DOI: 10.1038/s41436-020-01046-0. View

4.
Vasques G, Funari M, Ferreira F, Aza-Carmona M, Sentchordi-Montane L, Barraza-Garcia J . IHH Gene Mutations Causing Short Stature With Nonspecific Skeletal Abnormalities and Response to Growth Hormone Therapy. J Clin Endocrinol Metab. 2017; 103(2):604-614. DOI: 10.1210/jc.2017-02026. View

5.
Vasques G, Amano N, Docko A, Funari M, Quedas E, Nishi M . Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature. J Clin Endocrinol Metab. 2013; 98(10):E1636-44. DOI: 10.1210/jc.2013-2142. View